- Home
- FICO vs RVTY Comparison
FICO vs RVTY Comparison
Compare FICO & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FICO | RVTY |
|---|---|---|
| Founded | 1956 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 17.0B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | FICO | RVTY |
|---|---|---|
| Price | $719.05 | $160.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 18 |
| Target Price | ★ $821.79 | $171.07 |
| AVG Volume (30 Days) | 853.7K | ★ 1.8M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.18% |
| EPS Growth | ★ 36.85 | N/A |
| EPS | ★ 36.32 | 0.82 |
| Revenue | $1,032,475,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $2.38 | $0.86 |
| Revenue Next Year | $6.72 | $5.51 |
| P/E Ratio | ★ $24.86 | $189.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $595.19 | $81.22 |
| 52 Week High | $1,858.91 | $171.74 |
Technical Indicators
Market Signals| Indicator | FICO | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 56.60 |
| Support Level | $671.19 | $143.39 |
| Resistance Level | $1,117.39 | $166.25 |
| Average True Range (ATR) | 41.50 | 7.46 |
| MACD | 3.99 | -0.93 |
| Stochastic Oscillator | 34.99 | 53.89 |
Price Performance
Historical ComparisonAbout FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac is a leading applied analytics company. It is primarily known for its FICO credit scores, a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.